DWP-213388

N/A

Report date: 2022/08/15 14:18:48
NME

Base Information

Drug NameDWP-213388
Drug Alias NameDWP-213388
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase BTK inhibitorsTyrosine-protein kinase ITK/TSK inhibitors
TargetsTyrosine-protein kinase BTKTyrosine-protein kinase ITK/TSK
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVitalli BioDaewoong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A